| Disease | metabolic syndrome x | 
| Comorbidity | C0003873|rheumatoid disease | 
| Sentences | 1 | 
| PubMedID- 25345753 | Expert opinion: the available data supports the concept that targeting inflammation improves insulin sensitivity and beta-cell function; it also ameliorates glucose control in insulin-resistant patients with inflammatory rheumatoid diseases as well in patients with metabolic syndrome or t2dm. | 
Page: 1 


